Navigation Links
American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
Date:5/27/2008

NEW YORK, May 27 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Rexahn Pharmaceuticals, Inc. under the ticker symbol RNN.

Rexahn Pharmaceuticals is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.

"We are pleased to welcome Rexahn Pharmaceuticals to the American Stock Exchange," said Neal Wolkoff, Chairman and CEO, of the Amex. "We look forward to working with Rexahn in building increased awareness and visibility within the investment community."

"As we continue to aggressively pursue our clinical development efforts, our listing on the Amex will increase shareholder value and provide expanded visibility to the investment community and capital markets, at large," stated Dr. Chang H. Ahn, Chairman and Chief Executive Officer of Rexahn.

The specialist for Rexahn Pharmaceuticals, Inc. is AGS Specialist Partners. For further information on RNN and other Amex-listed companies, please visit http://www.amex.com.

About American Stock Exchange

The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 401 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com.


'/>"/>
SOURCE American Stock Exchange
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Having proven that its ... African bio-technology company, Green Cell Technologies® (GCT®), has turned its attention ... challenging current outdated ‘pressing’ methods, ushering in a new era of modern, cost ...
(Date:8/22/2017)... ... August 22, 2017 , ... One ... is the practice of opioid-dose sparing. Opioid-dose sparing refers to the reduction of ... including with non-steroidal anti-inflammatory drugs (NSAIDs). , The potential for new therapies to ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... Chinese bio security firm, to bring its proprietary CANARY pathogen detection technology and ... relationship, the Chinese firm has purchased an undisclosed number of PathSensors’ Zephyr pathogen ...
(Date:8/18/2017)... ... August 18, 2017 , ... OAI, ... Semiconductor, MEMS, and Microfluidics Industries, announces the new Model 800E front and backside, ... in automated production mask aligners. OAI has already received and installed several ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/24/2017)... DUBLIN , Mar 24, 2017 Research ... Vehicle Access System Market Analysis & Trends - Industry Forecast to ... ... poised to grow at a CAGR of around 15.1% over the ... This industry report analyzes the market estimates and forecasts for ...
Breaking Biology News(10 mins):